By clicking "Accept All", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Global
Pharmaceutical
Leader
A global pharmaceutical leader facing career-making product launches when the world went remote. With hundreds of millions on the line, illi reimagined their meeting strategy around human connection, pioneering hybrid formats that brought energy back to isolated sales teams. The result: flawless execution, revenue targets hit, and a sustainable model for learning and connection.
2025
When COVID-19 forced everything virtual in 2020, a global pharmaceutical leader faced a defining moment: career-making product launches worth hundreds of millions, sales teams suddenly isolated, and no playbook for what came next.
The team thought they needed better virtual technology. The real need ran deeper: their people weren't just screen-fatigued, they were starving for connection. Sales professionals needed to feel equipped and energized, not endure another Zoom marathon. The gap wasn't technological. It was human.
These weren't just sales professionals adapting to remote work. They were launch teams under pressure to drive revenue despite distance, isolated from the energy of in-person collaboration, craving connection to each other and to the patients whose lives depended on their success.
Traditional conference formats were failing them. Two-hour sessions and back-to-back meetings didn't translate. They needed events reimagined around how people actually learn, connect, and build capability virtually.

We rethought the meeting structure entirely. Interactive training replaced passive presentations with real-time problem-solving, role-plays, and digestible learning experiences. Patient stories wove throughout, keeping teams connected to purpose, not just product.
We pioneered hybrid formats with regional watch parties that brought movie-in-the-park energy to go-to-market practice and team problem-solving. The platform drove engagement (personalized agendas, gamification, 33,000+ "virtual claps") but the strategy was empathy, not technology.

Dozens of high-profile launches executed flawlessly. Revenue targets met despite unprecedented disruption. Sales teams hit the field prepared, and business momentum never stopped.
The hybrid model became a sustainable advantage: ongoing learning and connection without the cost or constraint of single-location gatherings.
The pharma leader reached The Other Side, where technology serves the humans behind the business.

A riveting broadcast to hundreds of locations without a single hitch.
Further, their app was remarkably engaging – 97% positive feedback!
Their thoughtfulness and understanding of our business is unmatched.